Status:
UNKNOWN
Three-Year Trial on a New Testosterone Gel
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
Dr. August Wolff GmbH & Co. KG Arzneimittel
Conditions:
Hypogonadism
Eligibility:
MALE
18+ years
Phase:
PHASE3
Brief Summary
The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement the...
Detailed Description
The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement the...
Eligibility Criteria
Inclusion
- men with
- hypergonadotropic hypogonadism
- hypogonadotropic hypogonadism
- late-onset hypogonadism
- combined with an initial Testosterone serum level of \< 11 nmol/l
Exclusion
- known or suspected carcinoma of the prostate
- clinically relevant abnormalities in clinical chemistry or haematology
- any severe medical conditions at the opinion of the investigator
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00204269
Start Date
January 1 2003
End Date
September 1 2006
Last Update
May 15 2006
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Charité, Division of Urology
Berlin, Germany, 10117
2
Franziskus-Hospital, Division of Urology
Bielefeld, Germany, 33615
3
University Clinic Bonn, Division of Dermatology
Bonn, Germany, 53105
4
Medical University Clinic II, Division of Internal Medicine/Andrology
Cologne, Germany, 50924